Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Novartis AG

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
58/100
Moderate Influence
$13.1M
Total Lobby Spend
5
Policy Issues
9
Lobbyists
3
Revolving Door

Novartis AG reported $13.1 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Securities & Exchange Commission
Dept of Agriculture
Environmental Protection Agency
Office of Management & Budget
U.S. House of Representatives
U.S. Senate

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecCapitol Counsel
PHATRDGOV
3$679K
2024 Jul-SepWilliams & Jensen
PHAGOVMED+2
4$512K
2024 Apr-JunVenable LLP
TRDMEDHCR+1
4$537K
2024 Jan-MarDLA Piper
GOVTRDHCR
4$710K
2023 Oct-DecCovington & Burling
HCRPHATRD+1
4$694K
2023 Jul-SepVan Scoyoc Associates
PHATRDHCR
1$538K
2023 Apr-JunMehlman Consulting
PHATRDMED+1
1$664K
2023 Jan-MarSteptoe & Johnson
TRDHCRPHA+1
4$678K

Novartis AG Lobbying FAQ

Novartis AG has spent $13.1M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.

Novartis AG lobbies on 5 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Trade. These disclosures are filed quarterly with the Senate Office of Public Records.

Novartis AG has an Influence Score of 58/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Novartis AG employs 9 registered lobbyists, of whom 3 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Novartis AG has contacted 6 government entities as part of their lobbying activities, including Securities & Exchange Commission, Dept of Agriculture, Environmental Protection Agency.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.